![Efthymios Deliargyris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Efthymios Deliargyris
Chief Tech/Sci/R&D Officer at
CYTOSORBENTS CORPORATION
Net worth: 154 084 $ as of 31/08/2026
Profile
Efthymios N.
Deliargyris is currently Chief Medical Officer at CytoSorbents Corp.
since 2020.
Formerly, served as Chief Medical Officer at PLx Pharma, Inc. from 2018 to 2020, Director-Cardiology & Interventional Cardiology at Athens Medical Center SA from 2004 to 2010, and Assistant Professor at Wake Forest University from 2001 to 2004.
Education includes a doctorate from National & Kapodistrian University of Athens.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/06/2026 | 451,859 ( 0.72% ) | 154 084 $ | 31/08/2026 |
Efthymios Deliargyris active positions
| Companies | Position | Start |
|---|---|---|
| CYTOSORBENTS CORPORATION | Chief Tech/Sci/R&D Officer | 01/05/2020 |
Former positions of Efthymios Deliargyris
| Companies | Position | End |
|---|---|---|
| PLX PHARMA WINDDOWN CORP. | Chief Tech/Sci/R&D Officer | 30/04/2020 |
| ATHENS MEDICAL C.S.A. | Corporate Officer/Principal | 01/01/2010 |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2004 |
Training of Efthymios Deliargyris
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
82
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Athens Medical Center SA
 Athens Medical Center SA Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Wake Forest University
Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National & Kapodistrian University of Athens
 National & Kapodistrian University of Athens Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoSorbents Corp.
 CytoSorbents Corp. Medical SpecialtiesHealth Technology Develops products to support healthcare professionals in the treatment of complex medical conditions | Health Technology |
PLx Pharma, Inc.
 PLx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops liquid-filled aspirin capsules for pain management | Health Technology |
- Stock Market
- Insiders
- Efthymios Deliargyris
